Neutralizing Antibody Test
Th cPass® Neutralizing Antibody test is designed to provide individuals with critical information on their body’s ability to defend itself against COVID-19. Neutralizing antibodies are the specific marker for COVID-19, and cPass® is the only test on the market that is FDA emergency authorization approved that targets these markers. Not all antibodies specifically mark COVID-19, and no other general ‘antibodies’ test pinpoints COVID-19 fighting neutralizing antibodies like ours does.
This one-of-a-kind at-home test indicates the presence of neutralizing antibodies that can detect past COVID-19 infections, vaccine effectiveness, and potential immunities.
How Epitome Risk’s Neutralizing Antibody Test Works:
- Order test here
- Gather sample collection with full Epitome assistance
- Ship directly to our lab (FourthWall Testing) in pre-paid, Pre-addressed package
- FourthWall Testing will determine presence of neutralizing antibodies
- FourthWall will provide a quick response via email with expert assessment of COVID-19 risk
For enterprise orders, please contact firstname.lastname@example.org
John Flaherty, Jr –